Covered recipient · General Payments record
SHARON ANN GOMEZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$1,177.89
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $331.68 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $70.47 | 4 |
| Novo Nordisk AS | $58.91 | 3 |
| ABBVIE INC. | $55.65 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.97 | 1 |
| Alexion Pharmaceuticals, Inc. | $24.95 | 1 |
| Corcept Therapeutics | $24.68 | 1 |
| SANOFI PASTEUR INC. | $20.00 | 1 |
| Seqirus USA Inc | $19.21 | 1 |
| Paratek Pharmaceuticals, Inc. | $17.01 | 1 |
| PFIZER INC. | $14.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.39 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233332 | CMS |
| ABBVIE INC. | $15.39 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233334 | CMS |
| ABBVIE INC. | $19.87 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233336 | CMS |
| Alexion Pharmaceuticals, Inc. | $24.95 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094025456 | CMS |
| Amgen Inc. | $17.56 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117262851 | CMS |
| Amgen Inc. | $17.83 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117564352 | CMS |
| Amgen Inc. | $18.39 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117564354 | CMS |
| Amgen Inc. | $16.69 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117564356 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.97 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118236848 | CMS |
| Corcept Therapeutics | $24.68 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117742800 | CMS |
| Novo Nordisk Inc | $19.28 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100385533 | CMS |
| Novo Nordisk Inc | $17.41 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100315700 | CMS |
| Novo Nordisk Inc | $22.22 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100261735 | CMS |
| Paratek Pharmaceuticals, Inc. | $17.01 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113928216 | CMS |
| PFIZER INC. | $14.83 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131409504 | CMS |
| SANOFI PASTEUR INC. | $20.00 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128741794 | CMS |
| Seqirus USA Inc | $19.21 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125639691 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.